Determination of SK and F 108566 (Teveten(R)) in human plasma by reversed-phase high-performance liquid chromatography

Journal of Chromatography B: Biomedical Applications

Volumn 707, Issue 1-2, 1998, Pages 328-333

  Lundberg Jr , David E ^a   Renee Person, C ^a   Knox, Stephanie ^a   Cyronak, Matthew J ^a  

^a Dept Drug Metab and Pharmacokin SmithKline Beecham P ^*  (United States)

Author keywords

Eprosartan; Teveten

Indexed keywords

EPROSARTAN;

ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; HUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION;

EID: 0344431303     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00598-7     Document Type: Article

References (5)

1. Ilson B., Boike S., Freed M., Everitt D., Brown L., Zariffa N., Jorkasky D. Clin. Pharmacol. Ther. 55:1994;206.
2. Ilson B., Tenero D., Knox S., Boike S., Audet A., Freed M., Everitt D., Brown L., Boyle D., Jorkasky D. Clin. Pharmacol. Ther. 55:1994;168.
3. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly P.P., Yacobi A., Layoff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. J. Pharm. Sci. 81:1992;309.
4. Lang J.R., Bolton S. J. Pharm. Biomed. Anal. 9:1991;357.
5. Buick A.R., Doig M.V., Jeal S.C., Land G.S., McDowall R.D. J. Pharm. Biomed. Anal. 8:1990;629.